Hepatitis C virus infection in Iceland: a recently introduced bloodborne disease
| Autor: | B. Stanzeit, A. Löve |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
Adult
Male Adolescent Epidemiology Hepatitis C virus Hepacivirus Population Iceland medicine.disease_cause Blood-borne disease Serology Blood-Borne Pathogens Prevalence medicine Humans Seroprevalence Hepatitis Antibodies Substance Abuse Intravenous education Aged Retrospective Studies education.field_of_study biology business.industry Hepatitis C Hepatitis C Antibodies Middle Aged medicine.disease biology.organism_classification Virology humanities Community-Acquired Infections Infectious Diseases Immunology population characteristics Female Viral disease business geographic locations Research Article |
| Zdroj: | Epidemiology and Infection. 113:529-536 |
| ISSN: | 1469-4409 0950-2688 |
| DOI: | 10.1017/s0950268800068540 |
| Popis: | SUMMARYThis study demonstrates a very high prevalence of antibodies to hepatitis C virus among Icelandic intravenous (i.v.) drug users. Of 152 identified i.v. drug users 95 (63%) were shown to have antibodies to the hepatitis C virus. In contrast the seroprevalence in the general Icelandic population is low, (0·2%). Almost all cases of hepatitis C virus infection in Iceland are due to i.v. drug use or to use of infected blood or blood products. Sporadic cases with unexplained modes of transmission, a significant portion of hepatitis C infections elsewhere, are virtually non-existent in Iceland. The results of this study are consistent with the hypothesis that the sporadic community-acquired cases could be caused by blood transfer due to bites from insect vectors such as mosquitoes which are not found in Iceland. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|